EBSCO Information Services launches Biotechnology Source for pharmaceutical and biotechnology companies

Dec 9, 2015

EBSCO Information Services (EBSCO) introduces a new information resource for researchers in the biotechnology and pharmaceutical industries. Biotechnology Source provides access to industry-leading, full-text journals from a single platform, and is designed to help companies gain a competitive edge by providing fast access to relevant, current and accurate information.

Biotechnology Source has a versatile, fully-customizable platform, and content that includes more than 8,700 full-text journals — including many unique titles available only through this tool. In addition, current journals are complemented by an extensive backfile.

Biotechnology Source is easily integrated into a company’s workflow for increased visibility and usage, and can conveniently be accessed via mobile devices. It provides increased discoverability to reliable information via top industry journals, ensuring that researchers are returning search results of value to their organizations.

Joe Tragert, Senior Director of Product Management, says Biotechnology Source helps researchers of all experience levels navigate an increasingly complex landscape of medical and pharmaceutical literature, while surfacing reliable information. “Results-oriented organizational researchers and corporate librarians don’t have time for complex and laborious search engines. They want answers and information fast. Biotechnology Source gives researchers immediate, one-click access to full-text primary literature that has been carefully vetted, so they know they can trust it to be reliable and relevant.”

For more information on Biotechnology Source, visit https://www.ebscohost.com/corporate-research/biotechnology-source

Our Office

Morgan Healey
The Old Vicarage, Market Street, Castle Donington, Derbyshire,
DE74 2JB, UK

View our privacy policy

Contact Us

+44 (0)1827 373750
mail@morganhealey.com

Office Hours

Mon-Fri: 9am - 5pm
Sat-Sun: Closed

Follow Us